InnoModels Biotechnology is a biotechnology company focused on the research and development of innovative Antibody-Dependent Cellular Cytotoxicity (ADCC). We are committed to providing disruptive therapeutic solutions in the field of cancer treatment by activating the immune system to accurately combat tumour cells and bring new hope to patients.
Company Mission:
The mission of InnoModels Biotechnology is to promote the advancement of ADCC technology through continuous innovation and research and development, and to provide safer and more effective treatment solutions for cancer patients. We are committed to becoming a global leader in the field of ADCC and building a better future for patients through superior scientific research and technological innovation.

Core Technologies and Products:
ADCC Enhancement Technology: We have advanced ADCC enhancement technology, which enhances the recognition and killing of tumour cells by immune cells through improving the structure of antibodies and increasing their binding affinity on immune cells.
Innovative Drug Development: InnoModels Biotechnology focuses on the development of ADCC-enhanced therapeutics for different cancer types. Our research team is constantly working to validate new therapeutic targets at preclinical and clinical stages to provide personalised treatment options for patients.
Partnerships: We have established strong partnerships with leading biopharmaceutical companies and research institutes around the world to promote the innovation and application of ADCC technologies. Through these partnerships, we will leverage the strengths of all parties to accelerate the development and launch of new drugs.
Research Team and Innovation Culture:
InnoModels Biotechnology has a team of senior industry experts and outstanding scientific research talents. We focus on building a culture of innovation and encourage our team members to actively propose new ideas and unique insights to promote cutting-edge research in the field of ADCC.
Social Responsibility and Sustainable Development:
As a socially responsible company, InnoModels Biotechnology cares about the sustainable development of life. We actively promote the integration of medical research and social responsibility, and are committed to providing more accessible treatment options for patients around the world.
In the future, InnoModels Biotechnology will continue to innovate and create a new chapter in the innovation and application of ADCC technology, bringing more chances of survival and hope for recovery to cancer patients. We firmly believe that through the power of science, we can change the face of cancer treatment and bring a better tomorrow for patients.